NTRB|Nutriband Inc|Price:2.910|Chg%:+0.030
This article provides an overview of Nutriband Inc. (NTRB), detailing its market trends, key financials, and analyst ratings. The company is engaged in developing transdermal pharmaceutical products, with a focus on abuse-deterrent technology, and analysts rate it as a "Buy" with significant upside potential …